NL7005168A - - Google Patents

Info

Publication number
NL7005168A
NL7005168A NL7005168A NL7005168A NL7005168A NL 7005168 A NL7005168 A NL 7005168A NL 7005168 A NL7005168 A NL 7005168A NL 7005168 A NL7005168 A NL 7005168A NL 7005168 A NL7005168 A NL 7005168A
Authority
NL
Netherlands
Application number
NL7005168A
Other versions
NL176269C (nl
NL176269B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH589569A external-priority patent/CH512490A/de
Application filed filed Critical
Publication of NL7005168A publication Critical patent/NL7005168A/xx
Publication of NL176269B publication Critical patent/NL176269B/xx
Application granted granted Critical
Publication of NL176269C publication Critical patent/NL176269C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NLAANVRAGE7005168,A 1969-04-18 1970-04-10 Werkwijze voor het bereiden van een lysergzuuramidederivaat. NL176269C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH589569A CH512490A (de) 1969-04-18 1969-04-18 Verfahren zur Herstellung von heterocyclischen Verbindungen
CH1326269 1969-09-02

Publications (3)

Publication Number Publication Date
NL7005168A true NL7005168A (de) 1970-10-20
NL176269B NL176269B (nl) 1984-10-16
NL176269C NL176269C (nl) 1985-03-18

Family

ID=25698602

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7005168,A NL176269C (nl) 1969-04-18 1970-04-10 Werkwijze voor het bereiden van een lysergzuuramidederivaat.

Country Status (9)

Country Link
US (1) US3755328A (de)
JP (1) JPS5416520B1 (de)
BE (1) BE749072A (de)
DE (1) DE2017560C2 (de)
DK (1) DK140373C (de)
FR (1) FR2043444A5 (de)
GB (1) GB1298277A (de)
NL (1) NL176269C (de)
SE (1) SE361173B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH587858A5 (de) * 1973-11-28 1977-05-13 Sandoz Ag
US4138565A (en) * 1975-05-31 1979-02-06 Sandoz Ltd. Stable solutions and processes for their preparation
CH619468A5 (de) * 1976-01-12 1980-09-30 Sandoz Ag
YU40004B (en) * 1977-07-21 1985-06-30 Lek Tovarna Farmacevtskih Praocess for preparing n-substituted esters of 9,10-dihydrlysergic acid
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
YU41110B (en) * 1978-07-19 1986-12-31 Lek Tovarna Farmacevtskih Process for preparing dextrorotatory ergot alcaloids acid addition salts
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5006526A (en) * 1988-10-17 1991-04-09 Louisiana State University Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
WO2011079313A1 (en) * 2009-12-23 2011-06-30 Map Pharmaceuticals, Inc. Novel ergoline analogs
US8604035B2 (en) 2011-06-23 2013-12-10 Map Pharmaceuticals, Inc. Fluoroergoline analogs
WO2013095707A1 (en) 2011-12-19 2013-06-27 Map Pharmaceuticals, Inc. Novel iso-ergoline derivatives
EP2793583A4 (de) 2011-12-21 2015-08-12 Map Pharmaceuticals Inc Neuartige neuromodulatorische verbindungen
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH395119A (de) * 1961-05-10 1965-07-15 Sandoz Ag Verfahren zur Herstellung von heterocyclischen Verbindungen
CH469735A (de) * 1965-11-02 1969-03-15 Sandoz Ag Verfahren zur Herstellung heterocyclischer Verbindungen
CH508628A (de) * 1968-06-25 1971-06-15 Sandoz Ag Verfahren zur Herstellung neuer heterocyclischer Verbindungen

Also Published As

Publication number Publication date
NL176269C (nl) 1985-03-18
NL176269B (nl) 1984-10-16
GB1298277A (en) 1972-11-29
DK140373B (da) 1979-08-13
DK140373C (da) 1980-01-07
JPS5416520B1 (de) 1979-06-22
DE2017560A1 (de) 1970-11-05
FR2043444A5 (de) 1971-02-12
US3755328A (en) 1973-08-28
SE361173B (de) 1973-10-22
DE2017560C2 (de) 1983-11-24
BE749072A (fr) 1970-10-16

Similar Documents

Publication Publication Date Title
AU2270770A (de)
AU465452B2 (de)
FR2043444A5 (de)
AU429630B2 (de)
AU450150B2 (de)
AU2355770A (de)
AU442375B2 (de)
AU427401B2 (de)
AU470301B1 (de)
AU442463B2 (de)
AU410358B2 (de)
AU428131B2 (de)
AT308690B (de)
AU425297B2 (de)
AU438128B2 (de)
AU470661B1 (de)
AU442285B2 (de)
AU442322B2 (de)
AU442357B2 (de)
AU417208B2 (de)
AU442380B2 (de)
AU428129B2 (de)
AU442535B2 (de)
AU442538B2 (de)
AU442554B2 (de)

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
V4 Discontinued because of reaching the maximum lifetime of a patent